Story perspectives

Dog's Cancer Vaccine: AI-Powered Breakthrough Cuts Tumor by 75%

3/17/2026

Summary

Story summary

Paul Conyngham, an Australian tech entrepreneur, developed a personalized mRNA cancer vaccine for his dog Rose.
He used AI tools such as ChatGPT and AlphaFold to sequence Rose's tumor DNA and identify mutations.
The University of New South Wales manufactured the vaccine.
Officials reported a 75% reduction in Rose's cancer.
UNSW Professor Pall Thordarson cautioned about the timeline but noted potential for broader applications in personalized medicine.

1 of 1

Story summary

Paul Conyngham, an Australian tech entrepreneur, developed a personalized mRNA cancer vaccine for his dog Rose.
He used AI tools such as ChatGPT and AlphaFold to sequence Rose's tumor DNA and identify mutations.
The University of New South Wales manufactured the vaccine.
Officials reported a 75% reduction in Rose's cancer.
UNSW Professor Pall Thordarson cautioned about the timeline but noted potential for broader applications in personalized medicine.